Revvity RVTY Diagnostics — Restructuring and contract termination charges, net
Discontinued — last reported Q3 '22
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The official record: Revvity’s 10-Q, filed November 14, 2022, on SEC EDGAR. View the filing →
Ask your AI about Revvity's diagnostics — restructuring and contract termination charges, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revvity's diagnostics — restructuring and contract termination charges, net?
- Revvity (RVTY) reported diagnostics — restructuring and contract termination charges, net of $1.12M in Q3 2022.
- How has Revvity's diagnostics — restructuring and contract termination charges, net changed year-over-year?
- Revvity's diagnostics — restructuring and contract termination charges, net increased by 206.6% year-over-year, from $366K to $1.12M.
- What does diagnostics — restructuring and contract termination charges, net mean?
- Net costs from restructuring activities within the Diagnostics segment.
- How do you interpret diagnostics — restructuring and contract termination charges, net?
- High charges indicate significant operational transformation, which may lead to future margin improvements.
- How does diagnostics — restructuring and contract termination charges, net compare across companies?
- Commonly disclosed as 'Restructuring Charges' in segment operating results.